[1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid

C41H41N9O3 — CID 135387963

IUPAC[1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid
SMILESCOc1ccc(Cn2nc(N3CCCc4c3ccnc4N=C(c3ccccc3)c3ccccc3)c3ncc(N4CCC(C)(NC(=O)O)CC4)nc32)cc1
InChIInChI=1S/C41H41N9O3/c1-41(46-40(51)52)20-24-48(25-21-41)34-26-43-36-38(44-34)50(27-28-15-17-31(53-2)18-16-28)47-39(36)49-23-9-14-32-33(49)19-22-42-37(32)45-35(29-10-5-3-6-11-29)30-12-7-4-8-13-30/h3-8,10-13,15-19,22,26,46H,9,14,20-21,23-25,27H2,1-2H3,(H,51,52)
InChIKeyPSHDPIPJZRHSRN-UHFFFAOYSA-N
MW707.84 g/mol
LogP7.16
Rot. Bonds9

About [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid

[1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid (PubChem CID 135387963) has the molecular formula C41H41N9O3 and a molecular weight of 707.84 g/mol. Its IUPAC name is [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid.

Molecular Properties

Compound Name[1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid
PubChem CID135387963
Molecular FormulaC41H41N9O3
Molecular Weight707.84 g/mol
Exact Mass707.33
IUPAC Name[1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid
SMILESCOc1ccc(Cn2nc(N3CCCc4c3ccnc4N=C(c3ccccc3)c3ccccc3)c3ncc(N4CCC(C)(NC(=O)O)CC4)nc32)cc1
InChIInChI=1S/C41H41N9O3/c1-41(46-40(51)52)20-24-48(25-21-41)34-26-43-36-38(44-34)50(27-28-15-17-31(53-2)18-16-28)47-39(36)49-23-9-14-32-33(49)19-22-42-37(32)45-35(29-10-5-3-6-11-29)30-12-7-4-8-13-30/h3-8,10-13,15-19,22,26,46H,9,14,20-21,23-25,27H2,1-2H3,(H,51,52)
InChIKeyPSHDPIPJZRHSRN-UHFFFAOYSA-N
XLogP7.16
TPSA133.89 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds9
Heavy Atoms53
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500707.84
LogP ≤ 57.16
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid?
The IUPAC name of [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid (CID 135387963) is [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid.
What is the SMILES notation for [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid?
The canonical SMILES for [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid is COc1ccc(Cn2nc(N3CCCc4c3ccnc4N=C(c3ccccc3)c3ccccc3)c3ncc(N4CCC(C)(NC(=O)O)CC4)nc32)cc1.
What is the InChIKey of [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid?
The InChIKey is PSHDPIPJZRHSRN-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H41N9O3/c1-41(46-40(51)52)20-24-48(25-21-41)34-26-43-36-38(44-34)50(27-28-15-17-31(53-2)18-16-28)47-39(36)49-23-9-14-32-33(49)19-22-42-37(32)45-35(29-10-5-3-6-11-29)30-12-7-4-8-13-30/h3-8,10-13,15-19,22,26,46H,9,14,20-21,23-25,27H2,1-2H3,(H,51,52).
What are the key properties of [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid?
[1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid has a molecular weight of 707.84 g/mol, XLogP of 7.16, 9 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[3-[5-(benzhydrylideneamino)-3,4-dihydro-2H-1,6-naphthyridin-1-yl]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid is sourced from PubChem (CID 135387963), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).